U.S. CitiesCity-Data Forum Index
Go Back   City-Data Forum > General Forums > Economics > Investing
 [Register]
Please register to participate in our discussions with 1.5 million other members - it's free and quick! Some forums can only be seen by registered members. After you create your account, you'll be able to customize options and access all our 15,000 new posts/day with fewer ads.
Jump to a detailed profile or search
site with Google Custom Search

Search Forums  (Advanced)
Business Search - 14 Million verified businesses
Search for:  near: 
Reply Start New Thread
 
Old 04-12-2012, 10:35 AM
 
5,268 posts, read 5,608,887 times
Reputation: 1790

Advertisements

ALXA with FDA decision due by May 4th.
TLON.OB with FDA decision due by May 13th.

50-50 chance, and one will be a big winner.

disclaimer: Seeking Alpha article discussed the merits of the above stocks and 2-3 others, that have May FDA rulings.
Reply With Quote Quick reply to this message

 
Old 04-14-2012, 04:04 PM
 
1,935 posts, read 2,242,216 times
Reputation: 870
do you mean these are penny stocks?
Reply With Quote Quick reply to this message
 
Old 04-14-2012, 04:37 PM
 
5,268 posts, read 5,608,887 times
Reputation: 1790
yes, both are under $1.00 per share.
Reply With Quote Quick reply to this message
 
Old 05-01-2012, 10:51 AM
 
362 posts, read 408,821 times
Reputation: 144
TLON with some appreciable momentum... if it keeps up, wont be a penny stock much longer.
Reply With Quote Quick reply to this message
 
Old 05-01-2012, 11:02 AM
 
5,268 posts, read 5,608,887 times
Reputation: 1790
On Monday, April 9th, Alexza Pharmaceuticals Inc (ALXA)’s Director, Gordon Ringold, made a $54,000 buy of ALXA, purchasing 100,000 shares at a cost of $0.54 each.

FDA DATE: May 4th
Another very closely watched PDUFA is for Alexza's (ALXA) Adusave (Staccato Ioxapine). Adusave was also delayed three months. The PDUFA was delayed due to an amendment to Adusave Risk Evaluation and Mitigation Strategy [REMS] portion of the NDA. Adusave is intended to treat agitation in patients with schizophrenia and bipolar disorder. I have not been a fan of Adusave for over a year now. Nevertheless, an FDA Advisory Committee voted 9-8, with 1 vote abstained, in favor

http://seekingalpha.com/article/5454...s?source=yahoo of approval of Adusave.
Reply With Quote Quick reply to this message
 
Old 05-01-2012, 01:59 PM
 
5,268 posts, read 5,608,887 times
Reputation: 1790
I am a proud owner, I think, of ALXA, at 63 cents.
FDA this week, earnings next week, and stock near all-time lows.
Reply With Quote Quick reply to this message
 
Old 05-08-2012, 04:46 PM
 
Location: Warwick, RI
2,059 posts, read 2,252,546 times
Reputation: 3080
ARNA has it's FDA Advisory Panel on Thursday, and things are looking good for a positive recommendation to the FDA. I'm in with a small position at $3.28 and plan to hold thru Friday. I don't speculate like this often, but this one is looking good. Do your own DD, but again, this one looks like a winner.
Reply With Quote Quick reply to this message
 
Old 05-08-2012, 04:52 PM
 
5,268 posts, read 5,608,887 times
Reputation: 1790
Quote:
Originally Posted by treasurekidd View Post
ARNA has it's FDA Advisory Panel on Thursday, and things are looking good for a positive recommendation to the FDA. I'm in with a small position at $3.28 and plan to hold thru Friday. I don't speculate like this often, but this one is looking good. Do your own DD, but again, this one looks like a winner.
I tried to get some yesterday near $2.55 but failed.
No way, I jump in at the current $3.38.
The news on May 10th is not approval, that comes late June, I think.

My ALXA was denied. I paid 63 cents and it is now 43 cents.
Not worth selling, so I'll become the dreaded "long term holder."
Reply With Quote Quick reply to this message
 
Old 05-09-2012, 05:56 PM
 
Location: Warwick, RI
2,059 posts, read 2,252,546 times
Reputation: 3080
Well, it's all up the the FDA Advisory committee tomorrow. Bought in at $3.28, closed today at $3.66. Trading will be halted tomorrow, so the decision happens tomorrow afternoon and she either soars or tanks Friday morning. I really think that ARNA has the science and the need for a new and novel approach to combat obesity on it's side, but it's still a gamble. We'll know by this time tomorrow. Sorry to hear about ALXA Howard.
Reply With Quote Quick reply to this message
 
Old 05-10-2012, 07:41 AM
 
5,268 posts, read 5,608,887 times
Reputation: 1790
Quote:
Originally Posted by treasurekidd View Post
Well, it's all up the the FDA Advisory committee tomorrow. Bought in at $3.28, closed today at $3.66. Trading will be halted tomorrow, so the decision happens tomorrow afternoon and she either soars or tanks Friday morning. I really think that ARNA has the science and the need for a new and novel approach to combat obesity on it's side, but it's still a gamble. We'll know by this time tomorrow. Sorry to hear about ALXA Howard.
The stock is trading pre-market.
When ALXA had their "day," it stopped trading around 1pm.

If ARNA is trading until around mid day, I may do something with options. The premiums are very huge.
The stock is $3.60 and the May 19th $4.00 call, to be sold, is over $1.00. Clearly the options are expecting a move greater than 30%.
Puts are high too. Over a $1.00 for a $3 put with breakeven way down at $2.00.
Reply With Quote Quick reply to this message
Please register to post and access all features of our very popular forum. It is free and quick. Over $68,000 in prizes has already been given out to active posters on our forum. Additional giveaways are planned.

Detailed information about all U.S. cities, counties, and zip codes on our site: City-data.com.


Reply
Please update this thread with any new information or opinions. This open thread is still read by thousands of people, so we encourage all additional points of view.

Quick Reply
Message:

Over $84,000 in prizes was already given out to active posters on our forum and additional giveaways are planned!

Go Back   City-Data Forum > General Forums > Economics > Investing

All times are GMT -6.

2005-2014, Advameg, Inc.

City-Data.com - Archive 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 - Top